4//SEC Filing
Ashar Bhavesh 4
Accession 0001104659-25-016615
CIK 0001773427other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:58 PM ET
Size
5.3 KB
Accession
0001104659-25-016615
Insider Transaction Report
Form 4
Ashar Bhavesh
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-02-20$61.19/sh−1,016$62,168→ 62,053 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 15, 2024.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.15 to $61.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001849740
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:58 PM ET
- Size
- 5.3 KB